Table 1.
Clinical Features and cardiovascular risk factors at the beginning of the study
| Clinical features | Group 1 T2DM |
Group 2 T2DM drug-naive |
Group 3 Control |
p |
|---|---|---|---|---|
| N = 978 | N = 221 | N = 50 | ||
| Age (years) | 60 ± 9 | 52 ± 10 | 57 ± 10 | < 0.001ac |
| Gender (M/F%) | 40% / 60% | 44% / 56% | 36% / 64% | 0.4 |
| BMI (kg/m2) | 30 ± 5 | 31 ± 5 | 29 ± 5 | 0.1 |
| History of Dyslipidemia (yes)% | 90% | 67% | 34% | < 0.00001* |
| History of Hypertension (yes)% | 75% | 40% | 42% | < 0.00001ab |
| Sedentary lifestyle (yes)% | 42% | 19% | 58% | < 0.00001* |
| Smoking (yes)% | 53% | 43% | 34% | 0.001ab |
T2DM Type 2 diabetes mellitus, BMI Body Mass Index, Group 1 Individuals with T2DM undergoing drug treatment, Group 2 Newly diagnosed drug-naive (< 3 months) patients with T2DM. Group 3 Patients without diabetes. *All groups differ between themselves. a Group 1 vs 2. b Group 1 vs 3 c Group 2 vs 3. Statistical significance was set at p < 0.05